Deutsche Bank Ag\ Alkermes Plc. Transaction History
Deutsche Bank Ag\
- $245 Billion
- Q1 2025
A detailed history of Deutsche Bank Ag\ transactions in Alkermes Plc. stock. As of the latest transaction made, Deutsche Bank Ag\ holds 206,835 shares of ALKS stock, worth $5.96 Million. This represents 0.0% of its overall portfolio holdings.
Number of Shares
206,835
Previous 224,670
7.94%
Holding current value
$5.96 Million
Previous $6.46 Million
5.7%
% of portfolio
0.0%
Previous 0.0%
Shares
37 transactions
Others Institutions Holding ALKS
# of Institutions
410Shares Held
177MCall Options Held
229KPut Options Held
436K-
Black Rock Inc. New York, NY29.1MShares$839 Million0.02% of portfolio
-
Vanguard Group Inc Valley Forge, PA18.2MShares$525 Million0.01% of portfolio
-
Price T Rowe Associates Inc Baltimore, MD11.8MShares$340 Million0.05% of portfolio
-
State Street Corp Boston, MA8.02MShares$231 Million0.01% of portfolio
-
Rtw Investments, LP New York, NY6.88MShares$198 Million3.72% of portfolio
About Alkermes plc.
- Ticker ALKS
- Exchange NASDAQ
- Sector Healthcare
- Industry Drug Manufacturers—Specialty & Generic
- Shares Outstandng 164,254,000
- Market Cap $4.73B
- Description
- Alkermes plc, a biopharmaceutical company, researches, develops, and commercializes pharmaceutical products to address unmet medical needs of patients in various therapeutic areas in the United States, Ireland, and internationally. Its marketed products include ARISTADA, an intramuscular injectable suspension for the treatment of schizophrenia; ...